|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
AccuType® IL28B
Test Code90251
CPT Codes
81283<br /> This test is for non-New York patient testing. For New York testing, please see Test Code 90252.
Preferred Specimen
5 mL whole blood collected in an EDTA (lavender-top) tube
Patient Preparation
Do not eat immediately prior to sample collection. If patient has eaten recently, rinse mouth with plain water.
Minimum Volume
2 mL
Other Acceptable Specimens
Whole blood collected in: ACD solution A or B (yellow-top) tube • Buccal swab collected in: DNA Genotek Oracollect Kit, or Celera DNA Collection Kit (follow collection kit instructions)
Instructions
Do not freeze whole blood.
Buccal Swab: Use only Celera/Copan DNA Collection Kit (Celera part # is 5002737) or DNA Genotek OraCollect Kit (OC-100). Follow collection kit instructions.
Buccal Swab: Use only Celera/Copan DNA Collection Kit (Celera part # is 5002737) or DNA Genotek OraCollect Kit (OC-100). Follow collection kit instructions.
Transport Temperature
Room temperature
Specimen Stability
Whole blood
Room temperature: 8 days
Refrigerated: 8 days
Frozen: Unacceptable
Buccal swab
Room temperature: 14 days
Refrigerated: Unacceptable
Frozen: Unacceptable
Room temperature: 8 days
Refrigerated: 8 days
Frozen: Unacceptable
Buccal swab
Room temperature: 14 days
Refrigerated: Unacceptable
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received frozen • Buccal swab received refrigerated • Incorrect collection device • Liquid has leaked from container/no liquid present
Methodology
Real-Time Polymerase Chain Reaction
Setup Schedule
Set up: Daily night; Report available: 3 days
Reference Range
See Laboratory Report
Clinical Significance
The C polymorphism in rs12979860 is strongly associated with a two fold greater sustained virological response in European, African American, and Hispanic populations. Knowledge of the host genotype of patients infected with HCV will aid in the clinical decision to initiate treatment with PegIFN and RBV (a 48 week course of interferon and ribavirin which has limited efficacy and is often poorly tolerated due to side effects that prevent patients from finishing treatment).